Biography
Dr. Sarker is the CEO and CTO of Waste Technologies, LLC (WTL) since 2013 and he is the sole owner of the company. WTL has been working on any waste turning into green fuel especially building 1st commercialization facility in Bridgeport, CT on Waste Plastic to Low Sulfur Diesel (Patent # US 8,927,797 B2) and he has 5 more patent is pending stage since 2011. Dr. Moinuddin Sarker received his Ph.D. in Chemistry from the University of Manchester Institute of Science and Technology (UMIST), Manchester, UK. He also has a Masters and a Bachelors degree, both in Chemistry, from the University of Chittagong, Bangladesh. Dr. Sarker is the inventor of the technology and product entitles: “Method for converting waste plastics to lower – molecular weight hydrocarbons, particularly hydrocarbon fuel materials and the hydrocarbon material produced thereby.†(Patent # US 8,927,797 B2). Dr. Sarker has more 115 research publications and written 6 books including chapters. He is a Chief, Full Editor, Co-Editors, Associate Editors and Reviewers in more than 100 peer review journals in around the globe. Dr. Sarker is a distinguished member of the more than 40 organization or associations such as, Royal Society of Chemistry (RSC), UK, American Chemical Society (ACS), American Physical Society (APS), American Institute of Chemical Engineering (AIChE), International Union of Pure and Applied Chemistry (IUPAC), Canadian Society for Chemistry (CSC), Chemical Institute of Canada (CIC), American Council on Renewable Energy (ACORE), Cleantech Forum International, Connecticut Technology Council, Alliance for Clean Energy of New York (ACENY), Society of Automobile Engineering (SAE) International, Society of Plastics Engineers (SPE), Vermont Renewable Energy, Sierra Club, Greenpeace International, Bangladesh Chemical Society (Life Member), Dhaka, Bangladesh and many more. Dr. Sarker also heads a humanitarian effort in Bangladesh “The Moinuddin and Anjuman Foundation, Inc.â€, helps provide essentials for the poor and underprivileged (www.moinandanjufoundation.com).
Research Interest
Method for converting waste plastics to lower – molecular weight hydrocarbons, particularly hydrocarbon fuel materials and the hydrocarbon material produced thereby
Biography
Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma†and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur†in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570â€. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa†of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name of Albert Schweizer. He has received the award for merits of National guild of pharmacists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.
Research Interest
His research interest focuses on Cancer.
Biography
Thomas J. Webster’s (H index: 84) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from RPI (M.S., 1997; Ph.D., 2000). Prof. Webster has graduated/supervised over 149 visiting faculty, clinical fellows, post-doctoral students, and thesis completing B.S., M.S., and Ph.D. students. He is the founding editor-in-chief of the International Journal of Nanomedicine (5-year impact factor of 5.03). Prof. Webster is a fellow of AIMBE, BMES, IUSBE, and NAI. He also served as the President of SFB. He has appeared on BBC, NBC, ABC, Fox News, and other news outlets talking about medicine.
Research Interest
Research Interest design, synthesis, and evaluation of nanomaterials for various medical applications, including self-assembled chemistries, nanoparticles, nanotubes, and nanostructured surfaces